Gene · 8764
Papers3,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 3,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Early detection of soluble CD27, BTLA, and TIM-3 predicts the development of nosocomial infection in pediatric burn patients. | Front Immunol | 2022 | 35958579 | PubTator, text mining | PubMed |
| The IFN-γ-related long non-coding RNA signature predicts prognosis and indicates immune microenvironment infiltration in uterine corpus endometrial carcinoma. | Front Oncol | 2022 | 35957871 | PubTator, text mining | PubMed |
| Comprehensive bioinformatic analysis of MMP1 in hepatocellular carcinoma and establishment of relevant prognostic model. | Sci Rep | 2022 | 35948625 | PubTator, text mining | PubMed |
| The correlation of BTLA rs1982809 polymorphism with cancer susceptibility: A meta-analysis of 8634 participators. | Medicine (Baltimore) | 2022 | 35945755 | PubTator, text mining | PubMed |
| Prognosis Analysis and Validation of Fatty Acid Metabolism-Related lncRNAs and Tumor Immune Microenvironment in Cervical Cancer. | J Immunol Res | 2022 | 35942212 | PubTator, text mining | PubMed |
| A signature constructed with mitophagy-related genes to predict the prognosis and therapy response for breast cancer. | Aging (Albany NY) | 2022 | 35939339 | PubTator, text mining | PubMed |
| Clinical M2 Macrophage-Related Genes Can Serve as a Reliable Predictor of Lung Adenocarcinoma. | Front Oncol | 2022 | 35936688 | PubTator, text mining | PubMed |
| Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma. | Front Immunol | 2022 | 35935940 | PubTator, text mining | PubMed |
| Gene-Based Variant Analysis of Whole-Exome Sequencing in Relation to Eosinophil Count. | Front Immunol | 2022 | 35935937 | PubTator, text mining | PubMed |
| Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4+ TCR-T Cells. | Front Immunol | 2022 | 35928827 | PubTator, text mining | PubMed |
| Spike-heparan sulfate interactions in SARS-CoV-2 infection. | Curr Opin Struct Biol | 2022 | 35926454 | PubTator, text mining | PubMed |
| RNA editing underlies genetic risk of common inflammatory diseases. | Nature | 2022 | 35922514 | PubTator, text mining | PubMed |
| A physical wiring diagram for the human immune system. | Nature | 2022 | 35922511 | PubTator, text mining | PubMed |
| Screening of cell-virus, cell-cell, gene-gene crosstalk among animal kingdom at single cell resolution. | Clin Transl Med | 2022 | 35917402 | PubTator, text mining | PubMed |
| Role of BTLA/HVEM network in development of gastric cancer. | Hum Immunol | 2022 | 35914980 | PubTator, text mining | PubMed |
| NOTCH1 mutation associates with impaired immune response and decreased relapse-free survival in patients with resected T1-2N0 laryngeal cancer. | Front Immunol | 2022 | 35911687 | PubTator, text mining | PubMed |
| Construction and Verification of a Fibroblast-Related Prognostic Signature Model for Colon Cancer. | Front Genet | 2022 | 35910200 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals the Mechanism of Natural Ovarian Ageing. | Front Endocrinol (Lausanne) | 2022 | 35909541 | PubTator, text mining | PubMed |
| Ferroptosis-Related lncRNA Signature Correlates with the Prognosis, Tumor Microenvironment, and Therapeutic Sensitivity of Esophageal Squamous Cell Carcinoma. | Oxid Med Cell Longev | 2022 | 35903713 | PubTator, text mining | PubMed |
| Comprehensive Analysis of the Aberrance and Functional Significance of Ferroptosis in Gastric Cancer. | Front Pharmacol | 2022 | 35903347 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8764/papers?page=54